Jointown(SH:600998) Ge Long Hui·2025-10-16 10:07Core Viewpoint - The approval of the drug "Gelong Bromide" by the National Medical Products Administration marks a significant milestone for the company, enhancing its product portfolio in the pharmaceutical sector [1] Company Summary - The company, through its subsidiary Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd., received the approval for the marketing application of Gelong Bromide on October 16, 2025 [1] - Gelong Bromide is a quaternary ammonium anticholinergic drug that selectively acts on the gastrointestinal tract, inhibiting gastric secretion and adjusting gastrointestinal motility [1] Product Details - Gelong Bromide can be used for treating gastric and duodenal ulcers, chronic gastritis, and as a maintenance treatment for chronic obstructive pulmonary disease (COPD) in adults, including chronic bronchitis and emphysema [1] - The drug specifically binds to and inhibits the M3 acetylcholine receptors in bronchial smooth muscle, leading to airway dilation [1]